Cartesian Therapeutics is a clinical-stage biopharmaceutical enterprise pioneering the development of advanced RNA-engineered cell therapies designed to treat severe autoimmune diseases and oncology indications. By leveraging proprietary technology that utilizes messenger RNA to transiently engineer living cells, the company aims to harness the therapeutic power of cell therapy while mitigating the severe toxicities, manufacturing complexities, and permanent genetic modifications associated with traditional cellular treatments.